These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 25914552)

  • 1. An innovative approach to the topical treatment of acne.
    Sparavigna A; Tenconi B; De Ponti I; La Penna L
    Clin Cosmet Investig Dermatol; 2015; 8():179-85. PubMed ID: 25914552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of topical spironolactone 5% cream in the treatment of acne: A pilot study.
    Ayatollahi A; Samadi A; Bahmanjahromi A; Robati RM
    Health Sci Rep; 2021 Sep; 4(3):e317. PubMed ID: 34250269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of 2 clindamycin 1%-benzoyl peroxide 5% topical gels used once daily in the management of acne vulgaris.
    Dhawan SS
    Cutis; 2009 May; 83(5):265-72. PubMed ID: 19537284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, double-blind, multicenter, parallel group study to compare relative efficacies of the topical gels 3% erythromycin/5% benzoyl peroxide and 0.025% tretinoin/erythromycin 4% in the treatment of moderate acne vulgaris of the face.
    Gupta AK; Lynde CW; Kunynetz RA; Amin S; Choi K; Goldstein E
    J Cutan Med Surg; 2003; 7(1):31-7. PubMed ID: 12362264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BPX-01 Minocycline Topical Gel Shows Promise for the Treatment of Moderate-to-severe Inflammatory Acne Vulgaris.
    Alexis A; Del Rosso JQ; Desai SR; Downie JB; Draelos ZD; Feser C; Forconi R; Fowler JF; Gold M; Kaufman-Janette J; Lain E; Lee M; Ling M; Shamban AT; Werschler WP; Daniels A
    J Clin Aesthet Dermatol; 2018 Nov; 11(11):25-35. PubMed ID: 30588271
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical Comparison of Topical 2.5% Benzoyl Peroxide plus 5% Niacinamide to 2.5% Benzoyl Peroxide Alone in the Treatment of Mild to Moderate Facial Acne Vulgaris.
    Kaewsanit T; Chakkavittumrong P; Waranuch N
    J Clin Aesthet Dermatol; 2021 Jun; 14(6):35-41. PubMed ID: 34804354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomised controlled multiple treatment comparison to provide a cost-effectiveness rationale for the selection of antimicrobial therapy in acne.
    Ozolins M; Eady EA; Avery A; Cunliffe WJ; O'Neill C; Simpson NB; Williams HC
    Health Technol Assess; 2005 Jan; 9(1):iii-212. PubMed ID: 15588555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical aminolaevulinic acid-photodynamic therapy for the treatment of acne vulgaris: a study of clinical efficacy and mechanism of action.
    Pollock B; Turner D; Stringer MR; Bojar RA; Goulden V; Stables GI; Cunliffe WJ
    Br J Dermatol; 2004 Sep; 151(3):616-22. PubMed ID: 15377348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, double-blind comparison of a clindamycin phosphate/benzoyl peroxide gel formulation and a matching clindamycin gel with respect to microbiologic activity and clinical efficacy in the topical treatment of acne vulgaris.
    Cunliffe WJ; Holland KT; Bojar R; Levy SF
    Clin Ther; 2002 Jul; 24(7):1117-33. PubMed ID: 12182256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clindamycin/benzoyl peroxide gel: a review of its use in the management of acne.
    Warner GT; Plosker GL
    Am J Clin Dermatol; 2002; 3(5):349-60. PubMed ID: 12069641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of combined azelaic acid cream plus oral minocycline with oral isotretinoin in severe acne.
    Gollnick HP; Graupe K; Zaumseil RP
    Eur J Dermatol; 2001; 11(6):538-44. PubMed ID: 11701404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and Safety of VB-1953 Topical Gel in Non-Responder Acne Patients with Clindamycin-Resistant Cutibacterium acnes.
    Batra R; Sadhasivam S; Saini S; Gupta S; Bisen RKS; Sinha M; Ghosh S; Jain S
    Drugs R D; 2020 Jun; 20(2):95-104. PubMed ID: 32222937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful treatment of mild to moderate acne vulgaris with Dr Michaels® (also branded as Zitinex®) topical products family: a clinical trial.
    Wollina U; Tirant M; Bayer P; Coburn M; Anderson P; Donnelly B; Kennedy T; Gaibor J; Arora M; Clews L; Walmsley S; Hercogovấ J; Fioranelli M; Gianfaldoni S; Chokoeva AA; Tchernev G; Novotny F; Roccia MG; Maximov GK; França K; Lotti T
    J Biol Regul Homeost Agents; 2016; 30(2 Suppl 3):49-54. PubMed ID: 27498658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multicenter efficacy and tolerability evaluation of benzoyl peroxide in a 10% urea vehicle for the treatment of acne vulgaris.
    Gold MH
    J Drugs Dermatol; 2006 May; 5(5):442-5. PubMed ID: 16703780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of 2% supramolecular salicylic acid compared with 5% benzoyl peroxide/0.1% adapalene in the acne treatment: a randomized, split-face, open-label, single-center study.
    Zheng Y; Yin S; Xia Y; Chen J; Ye C; Zeng Q; Lai W
    Cutan Ocul Toxicol; 2019 Mar; 38(1):48-54. PubMed ID: 30173582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Randomized, Double-Blind, Placebo-Controlled, Multicentric Study to Evaluate the Efficacy and the Tolerability of a Class II Medical Device in the Treatment of Mild and Moderate Acne.
    Fabbrocini G; Ferrillo M; Donnarumma M; Papale A; Pinto D; Rinaldi F
    Dermatol Ther (Heidelb); 2022 Aug; 12(8):1835-1845. PubMed ID: 35861908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SIG1273: a new cosmetic functional ingredient to reduce blemishes and Propionibacterium acnes in acne prone skin.
    Fernandéz JR; Rouzard K; Voronkov M; Feng X; Stock JB; Stock M; Gordon JS; Shroot B; Christensen MS; Pérez E
    J Cosmet Dermatol; 2012 Dec; 11(4):272-8. PubMed ID: 23174050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acne vulgaris.
    Williams HC; Dellavalle RP; Garner S
    Lancet; 2012 Jan; 379(9813):361-72. PubMed ID: 21880356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of probiotic-derived lotion from Lactobacillus paracasei MSMC 39-1 in mild to moderate acne vulgaris, randomized controlled trial.
    Sathikulpakdee S; Kanokrungsee S; Vitheejongjaroen P; Kamanamool N; Udompataikul M; Taweechotipatr M
    J Cosmet Dermatol; 2022 Oct; 21(10):5092-5097. PubMed ID: 35384257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of adapalene 0.1% / benzoyl peroxide 2.5% in the long-term treatment of predominantly moderate acne with or without concomitant medication - results from the non-interventional cohort study ELANG.
    Gollnick HP; Friedrich M; Peschen M; Pettker R; Pier A; Streit V; Jöstingmeyer P; Porombka D; Rojo Pulido I; Jäckel A
    J Eur Acad Dermatol Venereol; 2015 Jun; 29 Suppl 4():15-22. PubMed ID: 26059730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.